Ilaris (canakinumab) — Highmark
Gout flares
Initial criteria
- age ≥ 18 years
- diagnosis of gout flare
- prescribed by or in consultation with a rheumatologist
- therapeutic failure, contraindication, or intolerance to all of: NSAIDs, systemic corticosteroids, colchicine tablets
- receiving or will take concomitant urate-lowering medication (e.g., allopurinol, febuxostat, probenecid) unless contraindicated
Reauthorization criteria
- member is tolerating therapy AND has experienced disease improvement OR delayed disease progression